IP Library Granted Patent US 7,915,417
Granted Patent B2
US 7,915,417 · App. 12/189,443 · Granted Mar 29, 2011

Amino methylated 2-pyridinones

Assignee: Washington University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,915,417
App. No.
12/189,443
Granted
Mar 29, 2011
Kind
B2
Abstract

Novel amino methylated 2-pyridinones, precursors, intermediates, and derivatives; the methods for the preparation of the same; uses of the same for inhibiting pili formation in bacteria; and pharmaceutical compositions comprising these compounds are described in this application. The present compounds may be employed to inhibit biofilm formation and thereby inhibit adherence of bacteria to a host cell.

Claims (27)

1. The amino methylated 2-pyridinone corresponding to Formula VIa or a salt thereof:

wherein

R 2 and R 3 are independently hydrogen, hydrocarbyl, substituted hydrocarbyl or heterocyclo or, in combination with the nitrogen atom to which they are bonded, form a heterocyclo, provided at least one of R 2 and R 3 is other than hydrogen;

R 4 and R 5 are independently hydrogen, hydrocarbyl, substituted hydrocarbyl, or heterocyclo, provided at least one of R 4 and R 5 is other than hydrogen;

X 5 is —C(H)—;

X 33 is an electron pair or oxo;

X 44 is hydrogen or hydrocarbyl;

X 55 is —CO 2 X 555 ; and

X 555 is hydrogen, a cation, hydrocarbyl, substituted hydrocarbyl, or heterocyclo.

2. The amino methylated 2-pyridinone of claim 1 wherein X 44 is hydrogen or alkyl.

3. The amino methylated 2-pyridinone of claim 1 wherein X 555 is an alkali metal.

4. The amino methylated 2-pyridinone of claim 1 wherein R 2 and R 3 are independently hydrogen, hydrocarbyl, substituted hydrocarbyl or heterocyclo, provided at least one of R 2 and R 3 is other than hydrogen.

5. The amino methylated 2-pyridinone of claim 1 wherein (i) R 2 and R 3 are independently hydrogen, hydrocarbyl, substituted hydrocarbyl or heterocyclo, and (ii) X 44 is hydrogen or hydrocarbyl.

6. The amino methylated 2-pyridinone of claim 1 wherein R 2 is alkyl.

7. The amino methylated 2-pyridinone of claim 1 wherein R 2 and R 3 , in combination with the nitrogen atom to which they are bonded form a heterocyclo.

8. The amino methylated 2-pyridinone of claim 1 wherein R 4 is alkyl or aryl.

9. The amino methylated 2-pyridinone of claim 1 wherein R 5 is alkyl.

10. A compound having the formula

wherein R 1 is phenyl, R 2 is methyl, R 3 is NMe 2 and Me is methyl.

11. A process for inhibiting adherence of a bacteria to a host cell, the process comprising treating the bacteria with a compound of claim 1 or a salt thereof.

12. A process for inhibiting adherence of a bacteria to a host cell, the process comprising treating the bacteria with a compound of claim 2 or a salt thereof.

13. A compound having the formula

wherein R 1 is phenyl, R 2 is —CH 2 -1-naphthyl, R 3 is NMe 2 , and Me is methyl.

14. A compound having the formula

wherein R 1 is phenyl, R 2 is —CH 2 -1-naphthyl, R 3 is morpholine.

15. A compound having the formula

wherein R 1 is cyclopropyl, R 2 is —CH 2 -1-naphthyl, R 3 is NMe 2 and Me is methyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2015
From: HULTGREN, SCOTT J.; PINKNER, JEROME S.; ALMQVIST, FREDRIK; PEMBERTON, NILS; ABERG, VERONICA; LARSSON, ANDREAS
To: WASHINGTON UNIVERSITY
Reel/Frame 036349/0073 →
CONFIRMATORY LICENSE Recorded Feb 27, 2012
From: WASHINGTON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027762/0613 →
Continuity (4)
Continuation 11581518 · Oct 16, 2006
Continuation In Part PCTUS2005013032 · Apr 14, 2005
Provisional Application 60563082 · Apr 16, 2004
Related Publication 20080311644A1 · Dec 18, 2008